Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Nykode Therapeutics ASA Director's Dealing 2023

Oct 25, 2023

3695_dirs_2023-10-25_4f1118f7-fe48-41cc-8fc9-a51341adbde8.html

Director's Dealing

Open in viewer

Opens in your device viewer

Nykode Therapeutics - Mandatory notification of trade by closely associated party of a primary Insider

Nykode Therapeutics - Mandatory notification of trade by closely associated party of a primary Insider

Oslo, Norway, October 25, 2023

Victoria India Fund AS has today acquired 450,000 shares in Nykode Therapeutics ASA at an average price of NOK 18.0244 per share. Christian Åbyholm is a Member of the Board of Victoria India Fund AS and is a Member of the Board of Directors and primary insider in Nykode Therapeutics ASA. Following the transaction Victoria India Fund AS holds 17,705,175 shares in the Nykode Therapeutics ASA.

Caaby AS has today acquired 50,000 shares in Nykode Therapeutics ASA at an average price of NOK 18.0244 per share. Christian Åbyholm is the owner of Caaby AS and is a Member of the Board of Directors and primary insider in Nykode Therapeutics ASA. Following the transaction Christian Åbyholm holds 2,055,295 shares in Nykode Therapeutics ASA through Caaby AS and 100,000 shares directly.

For further details, please see the attached forms.